Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Glioblastoma
Annick Desjardins, MDmonoclonal_antibodyPhase 2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 36/ 100
- Competitive Position
- 65/ 100
Competitive context
341 Active assets in the Glioblastoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Depatuxizumab Mafodotin AbbVie | Phase 3 | BB |
Cintredekin Besudotox INSYS Therapeutics Inc | Phase 3 | BB |
(+)-Vincristine University of Cincinnati | Phase 3 | BB |
Irinotecan University of Cincinnati | Phase 3 | BB |
Camustine Leland Metheny | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →